Moderna’s COVID-19 Second Booster Authorization Largely Thanks To Pfizer/BioNTech Data

 
• By Sue Sutter
  
Piggy back
Moderna piggybacked on Pfizer/BioNTech's data for a second booster shot. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet